425 research outputs found

    Plasma density measurements using chirped pulse broad-band Raman amplification

    Get PDF
    Stimulated Raman backscattering is used as a non-destructive method to determine the density of plasma media at localized positions in space and time. By colliding two counter-propagating, ultra-short laser pulses with a spectral bandwidth larger than twice the plasma frequency, amplification occurs at the Stokes wavelengths, which results in regions of gain and loss separated by twice the plasma frequency, from which the plasma density can be deduced. By varying the relative delay between the laser pulses, and therefore the position and timing of the interaction, the spatio-temporal distribution of the plasma density can be mapped out

    Chirped pulse Raman amplification in plasma: high gain measurements

    Get PDF
    High power short pulse lasers are usually based on chirped pulse amplification (CPA), where a frequency chirped and temporarily stretched ``seed'' pulse is amplified by a broad-bandwidth solid state medium, which is usually pumped by a monochromatic ``pump'' laser. Here, we demonstrate the feasibility of using chirped pulse Raman amplification (CPRA) as a means of amplifying short pulses in plasma. In this scheme, a short seed pulse is amplified by a stretched and chirped pump pulse through Raman backscattering in a plasma channel. Unlike conventional CPA, each spectral component of the seed is amplified at different longitudinal positions determined by the resonance of the seed, pump and plasma wave, which excites a density echelon that acts as a "chirped'" mirror and simultaneously backscatters and compresses the pump. Experimental evidence shows that it has potential as an ultra-broad bandwidth linear amplifier which dispenses with the need for large compressor gratings

    Renal involvement follows cardiac enlargement in essential hypertension

    Get PDF
    To assess the relationship between early clinically detectable involvement of hypertensive vascular disease in heart and kidneys, we obtained systemic and renal hemodynamic and M-mode echocardiographic measurements in 65 patients with essential hypertension. The results indicate that patients with and without left ventricular hypertrophy had similar renal hemodynamic findings. In contrast, patients with altered renal hemodynamic measurements (ie, reduced renal distribution of cardiac output and, therefore, absolute renal blood flow with increased renal vascular resistance) and increased serum uric acid levels also had increased left ventricular posterior and septal wall thicknesses and mass index. Moreover, these data also demonstrated that in patients with altered renal hemodynamics, the lower the renal distribution of cardiac output and the higher the serum uric acid levels, the greater were the indexes of cardiac enlargement. These results demonstrated that the pathophysiological and hemodynamic effects of essential hypertension in the heart precede those in the kidneys

    Wing Weight Optimization Under Aeroelastic Loads Subject to Stress Constraints

    Get PDF
    A minimum weight optimization of the wing under aeroelastic loads subject to stress constraints is carried out. The loads for the optimization are based on aeroelastic trim. The design variables are the thickness of the wing skins and planform variables. The composite plate structural model incorporates first-order shear deformation theory, the wing deflections are expressed using Chebyshev polynomials and a Rayleigh-Ritz procedure is adopted for the structural formulation. The aerodynamic pressures provided by the aerodynamic code at a discrete number of grid points is represented as a bilinear distribution on the composite plate code to solve for the deflections and stresses in the wing. The lifting-surface aerodynamic code FAST is presently being used to generate the pressure distribution over the wing. The envisioned ENSAERO/Plate is an aeroelastic analysis code which combines ENSAERO version 3.0 (for analysis of wing-body configurations) with the composite plate code

    COMPREHENSIVE CALCULATION-BASED IMRT QA USING R&V DATA, TREATMENT RECORDS, AND A SECOND TREATMENT PLANNING SYSTEM

    Get PDF
    Purpose: Traditional patient-specific IMRT QA measurements are labor intensive and consume machine time. Calculation-based IMRT QA methods typically are not comprehensive. We have developed a comprehensive calculation-based IMRT QA method to detect uncertainties introduced by the initial dose calculation, the data transfer through the Record-and-Verify (R&V) system, and various aspects of the physical delivery. Methods: We recomputed the treatment plans in the patient geometry for 48 cases using data from the R&V, and from the delivery unit to calculate the “as-transferred” and “as-delivered” doses respectively. These data were sent to the original TPS to verify transfer and delivery or to a second TPS to verify the original calculation. For each dataset we examined the dose computed from the R&V record (RV) and from the delivery records (Tx), and the dose computed with a second verification TPS (vTPS). Each verification dose was compared to the clinical dose distribution using 3D gamma analysis and by comparison of mean dose and ROI-specific dose levels to target volumes. Plans were also compared to IMRT QA absolute and relative dose measurements. Results: The average 3D gamma passing percentages using 3%-3mm, 2%-2mm, and 1%-1mm criteria for the RV plan were 100.0 (σ=0.0), 100.0 (σ=0.0), and 100.0 (σ=0.1); for the Tx plan they were 100.0 (σ=0.0), 100.0 (σ=0.0), and 99.0 (σ=1.4); and for the vTPS plan they were 99.3 (σ=0.6), 97.2 (σ=1.5), and 79.0 (σ=8.6). When comparing target volume doses in the RV, Tx, and vTPS plans to the clinical plans, the average ratios of ROI mean doses were 0.999 (σ=0.001), 1.001 (σ=0.002), and 0.990 (σ=0.009) and ROI-specific dose levels were 0.999 (σ=0.001), 1.001 (σ=0.002), and 0.980 (σ=0.043), respectively. Comparing the clinical, RV, TR, and vTPS calculated doses to the IMRT QA measurements for all 48 patients, the average ratios for absolute doses were 0.999 (σ=0.013), 0.998 (σ=0.013), 0.999 σ=0.015), and 0.990 (σ=0.012), respectively, and the average 2D gamma(5%-3mm) passing percentages for relative doses for 9 patients was were 99.36 (σ=0.68), 99.50 (σ=0.49), 99.13 (σ=0.84), and 98.76 (σ=1.66), respectively. Conclusions: Together with mechanical and dosimetric QA, our calculation-based IMRT QA method promises to minimize the need for patient-specific QA measurements by identifying outliers in need of further review

    Fixed-parameter tractability of the weighted edge clique partition problem

    Get PDF
    We develop an FPT algorithm and a compression for the Weighted Edge Clique Partition (WECP) problem, where a graph with n vertices and integer edge weights is given together with an integer k, and the aim is to find k cliques, such that every edge appears in exactly as many cliques as its weight. The problem has been previously only studied in the unweighted version called Edge Clique Partition (ECP), where the edges need to be partitioned into k cliques. It was shown that ECP admits a kernel with k2 vertices [Mujuni and Rosamond, 2008], but this kernel does not extend to WECP. The previously fastest algorithm known for ECP has a runtime of 2O(k2)nO(1) [Issac, 2019]. For WECP we develop a compression (to a slightly more general problem) with 4k vertices, and an algorithm with runtime 2O(k3/2w1/2 log(k/w))nO(1), where w is the maximum edge weight. The latter in particular improves the runtime for ECP to 2O(k3/2 logk)nO(1)

    Chirped pulse Raman amplification in plasma

    Get PDF
    Raman amplification in plasma has been proposed to be a promising method of amplifying short radiation pulses. Here, we investigate chirped pulse Raman amplification (CPRA) where the pump pulse is chirped and leads to spatiotemporal distributed gain, which exhibits superradiant scaling in the linear regime, usually associated with the nonlinear pump depletion and Compton amplification regimes. CPRA has the potential to serve as a high-efficiency high-fidelity amplifier/compressor stage

    Pepper-pot emittance measurement of laser-plasma wakefield accelerated electrons

    Get PDF
    The transverse emittance is an important parameter governing the brightness of an electron beam. Here we present the first pepper-pot measurement of the transverse emittance for a mono-energetic electron beam from a laser-plasma wakefield accelerator, carried out on the Advanced Laser-Plasma High Energy Accelerators towards X-Rays (ALPHA-X) beam line. Mono-energetic electrons are passed through an array of 52 mu m diameter holes in a tungsten mask. The pepper-pot results set an upper limit for the normalised emittance at 5.5 +/- 1 pi mm mrad for an 82 MeV beam

    Development of StressCheck: A telehealth motivational enhancement therapy to improve voluntary engagement for PTSD treatment among active-duty service members

    Get PDF
    Background: Rates of PTSD in active-duty military are high relative to the general population. Although efficacious treatments exist, they are underutilized. Many service members with PTSD do not present for treatment and, of those who do, many do not receive sufficient doses of the interventions to receive full benefits. Motivational Enhancement Therapy (MET) “check-ups”, are brief interventions designed to elicit treatment engagement for those who are not treatment-seeking. Methods: StressCheck is an MET for nontreatment seeking Army and Air Force personnel. StressCheck aims to improve PTSD and increase treatment engagement, especially around evidence-based interventions, as well as to decrease stigma about seeking mental health services and improve knowledge about treatment options. This paper describes the intervention components and process of treatment development. The paper also describes next steps in testing the effectiveness of the intervention. Conclusion: PTSD is associated with deleterious health, occupational, and psychological effects. If effective, this innovative intervention will bridge the gap between those who are not treatment seeking and existing services, thereby enhancing reach and impact of existing services
    corecore